Back to search results

Telehealth for Chronic High Blood Pressure in Pregnancy

This study is looking at whether using telehealth visits with remote blood pressure monitoring and health coaching is a good way to manage chronic high blood pressure (hypertension) during pregnancy, compared to standard in-person doctor visits. You might be able to join if you are a pregnant woman between 18 and 45 years old with a prior diagnosis of chronic high blood pressure. The study wants to see if this telehealth approach is practical and safe for you and your baby. The goal is to see if it's as feasible as regular care. The current status of this study is unclear, and it plans to enroll 60 participants.

Study design
This interventional study plans to enroll 60 women and compares telehealth visits with remote blood pressure monitoring to standard in-person care.
What's involved
Participation will last until your baby is delivered. If assigned to telehealth, you will have alternating telehealth and in-person visits every two weeks until week 31 of your pregnancy.
Compensation
Not stated in the trial record.
Follow-up
The primary goals of the study are measured at Gestational Week 31.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07356518

Telehealth and Remote Blood Pressure

Recruiting
NAAges 18–45InterventionalTreatment
Wake Forest University Health Sciences
~60 participants
Updated 2026-04-27 on ClinicalTrials.gov
What's tested:Telehealth visitsIn-person visits

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of telehealth with remote BP telemonitoring compared to standard care
Measured over Gestational Week 31
+1 more outcome measured

Conditions

Hypertension
Hypertension in Pregnancy

Explore related trials

Gestational HypertensionHypertension

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Aderonke O Adeniyi, MD, MS · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

Who to contact

Ejiro Obioma, MBBS MMCi
[email protected]
704-355-2000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

prior diagnosis of Chronic hypertension (cHTN)
Pregnant women
Known: documented diagnosis or on antihypertensive medication prior to pregnancy

Exclusion

Any significant chronic medical or psychiatric illness that, in the investigator's opinion, would prevent participation in the study
Cardiac disorders: cardiomyopathy, angina, Coronary Artery Disease (CAD)
Current substance abuse disorder
Multifetal pregnancy
Participation in another study without prior approval
Plan to deliver outside Atrium Health Wake Forest Baptist
Prior stroke
Severe hypertension
Suspected or known fetal major structural/chromosomal abnormality or fetal demise

What this trial measures

  • Feasibility of telehealth with remote BP telemonitoring compared to standard careGestational Week 31

    willingness to enroll (number of patients enrolled divided by number of patients reached), study completion rate, adherence compared to standard care). Adherence will be defined as taking medication at least ≥80% of the time, recording ≥70% of weekly BP readings in the intervention group only and completing ≥70% of antenatal telehealth/clinic visits.

  • Safety of telehealth combined with telemonitoring compared to standard careGestational Week 31

    The number of adverse events reported (hypotension, syncope or hospitalization/emergency room visit for severe HTN